Fertility and Reproductive Outcome After Tubal Ectopic Pregnancy: Comparison Among Methotrexate, Surgery and Expectant Management

Overview

Journal Arch Gynecol Obstet

Specialty Gynecology & Obstetrics

Date 2020 Aug 28

PMID 32852572

Citations 14

Authors

Silvia Baggio

Simone Garzon

Anna Russo

Cesare Quintino Ianniciello

Lorenza Santi

Antonio Simone Lagana

Ricciarda Raffaelli

Massimo Franchi

Affiliations

Soon will be listed here.

Abstract

Purpose: To compare fertility and reproductive outcome after surgical, medical, and expectant management for tubal ectopic pregnancy (EP).

Methods: 133 of 228 patients, who were managed between January 2012 and December 2017 for a tubal EP, tried to conceive immediately after treatment: 86 out of 173 (49.7%) underwent surgical treatment; 38 (21.9%) were treated with methotrexate (MTX), and 49 (28.3%) had expectant management. Clinical data were retrieved by medical records, fertility outcomes were obtained by phone follow-up. The cumulative incidence (CI) of intrauterine clinical pregnancy (CP), miscarriage, live birth (LB), and recurrent EP, and the time between treatment and first intrauterine CP were compared between women treated with MTX, surgery and expectant management.

Results: The CI of intrauterine CP starting from 12 months after the EP was 65.3% for the expectant management, 55.3% for the MTX group, and 39.5% for surgery (p = 0.012). Post-hoc analysis showed expectant management having higher intrauterine CP and LB, and shorter time between treatment and first intrauterine CP compared to surgery (p < 0.05). The CI of recurrent EP was comparable between the 3 groups. The analysis stratified per βhCG cut-off of 1745 mUI/mL and EP mass cut-off of 25 mm reported consistent results.

Conclusions: Women successfully managed by expectation appear to have better reproductive outcomes compared to women who underwent surgery, with the shortest time to achieve a subsequent intrauterine CP. Therefore, if safely applicable the expectant management should be considered in the case of tubal EP. The fact that the chosen treatment was primarily guided by the βhCG value and EP mass diameter based on the protocol, which is intrinsically related to the characteristics of the EP, represents the main limitation of the present study. Indeed, we cannot completely exclude that the observed differences between treatments are related to the EP itself instead of the treatment.

Citing Articles

Analysis of ectopic pregnancies requiring life-saving urgent surgery.

Firatligil F, Sucu S, Ustun Y Ulus Travma Acil Cerrahi Derg. 2025; 31(2):125-132.

PMID: 39963918 PMC: 11843420. DOI: 10.14744/tjtes.2024.86087.

Enhancing decision-making in tubal ectopic pregnancy using a machine learning approach to expectant management: a clinical article.

Jurman L, Brisker K, Ruach Hasdai R, Weitzner O, Daykan Y, Klein Z BMC Pregnancy Childbirth. 2024; 24(1):825.

PMID: 39702186 PMC: 11660628. DOI: 10.1186/s12884-024-07035-4.

The Effectiveness of Letrozole Alone or in Combination with Methotrexate in the Management of Ectopic Pregnancy, A Systematic Review and Meta-Analysis.

Tarafdari A, Keikha F, Asadi F, Hantoushzadeh S, Kohandel Gargari O, Forouzin M Reprod Sci. 2024; 31(12):3651-3659.

PMID: 39384737 DOI: 10.1007/s43032-024-01712-7.

Comparison of 2-year reproductive outcomes of tubal ectopic pregnancies treated with surgery, methotrexate or expectant management.

Firatligil F, Sucu S, Sucu S, Ozkan M, Akdas Reis Y, Dereli M Arch Gynecol Obstet. 2024; 310(5):2561-2568.

PMID: 39331053 DOI: 10.1007/s00404-024-07747-0.

Ruptured Recurrent Interstitial Ectopic Pregnancy Successfully Managed by Laparoscopy.

Ungureanu C, Stanculea F, Iordache N, Georgescu T, Ginghina O, Mihailov R Diagnostics (Basel). 2024; 14(5).

PMID: 38472978 PMC: 10931036. DOI: 10.3390/diagnostics14050506.

References

Rantala M, Makinen J . Tubal patency and fertility outcome after expectant management of ectopic pregnancy. Fertil Steril. 1998; 68(6):1043-6. DOI: 10.1016/s0015-0282(97)00414-7. View

Mol F, Mol B, Ankum W, van der Veen F, Hajenius P . Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis. Hum Reprod Update. 2008; 14(4):309-19. DOI: 10.1093/humupd/dmn012. View

Cohen A, Zakar L, Gil Y, Amer-Alshiek J, Bibi G, Almog B . Methotrexate success rates in progressing ectopic pregnancies: a reappraisal. Am J Obstet Gynecol. 2014; 211(2):128.e1-5. DOI: 10.1016/j.ajog.2014.03.043. View

Lloyd M, Carr M, McElhatton P, Hall G, Hughes R . The effects of methotrexate on pregnancy, fertility and lactation. QJM. 2000; 92(10):551-63. DOI: 10.1093/qjmed/92.10.551. View

Mol F, van Mello N, Strandell A, Strandell K, Jurkovic D, Ross J . Salpingotomy versus salpingectomy in women with tubal pregnancy (ESEP study): an open-label, multicentre, randomised controlled trial. Lancet. 2014; 383(9927):1483-1489. DOI: 10.1016/S0140-6736(14)60123-9. View

Kazandi M, Turan V . Ectopic pregnancy; risk factors and comparison of intervention success rates in tubal ectopic pregnancy. Clin Exp Obstet Gynecol. 2011; 38(1):67-70. View

Chen L, Zhu D, Wu Q, Yu Y . Fertility outcomes after laparoscopic salpingectomy or salpingotomy for tubal ectopic pregnancy: A retrospective cohort study of 95 patients. Int J Surg. 2017; 48:59-63. DOI: 10.1016/j.ijsu.2017.09.058. View

Jurkovic D, Memtsa M, Sawyer E, Donaldson A, Jamil A, Schramm K . Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial. Ultrasound Obstet Gynecol. 2016; 49(2):171-176. DOI: 10.1002/uog.17329. View

van Mello N, Mol F, Verhoeve H, van Wely M, Adriaanse A, Boss E . Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison. Hum Reprod. 2012; 28(1):60-7. DOI: 10.1093/humrep/des373. View

10.

Garzon S, Lagana A, Pomini P, Raffaelli R, Ghezzi F, Franchi M . Laparoscopic reversible occlusion of uterine arteries and cornuostomy for advanced interstitial pregnancy. Minim Invasive Ther Allied Technol. 2018; 28(6):359-362. DOI: 10.1080/13645706.2018.1547764. View

11.

Nama V, Manyonda I . Tubal ectopic pregnancy: diagnosis and management. Arch Gynecol Obstet. 2008; 279(4):443-53. DOI: 10.1007/s00404-008-0731-3. View

12.

Bouyer J, Job-Spira N, Pouly J, Coste J, Germain E, Fernandez H . Fertility following radical, conservative-surgical or medical treatment for tubal pregnancy: a population-based study. BJOG. 2000; 107(6):714-21. DOI: 10.1111/j.1471-0528.2000.tb13330.x. View

13.

Zohav E, Gemer O, Segal S . Reproductive outcome after expectant management of ectopic pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996; 66(1):1-2. DOI: 10.1016/0301-2115(95)02370-4. View

14.

Garzon S, Raffaelli R, Montin U, Ghezzi F . Primary hepatic pregnancy: report of a case treated with laparoscopic approach and review of the literature. Fertil Steril. 2018; 110(5):925-931.e1. DOI: 10.1016/j.fertnstert.2018.05.020. View

15.

Demirdag E, Guler I, Abay S, Oguz Y, Erdem M, Erdem A . The impact of expectant management, systemic methotrexate and surgery on subsequent pregnancy outcomes in tubal ectopic pregnancy. Ir J Med Sci. 2016; 186(2):387-392. DOI: 10.1007/s11845-016-1419-5. View

16.

Sivalingam V, Duncan W, Kirk E, Shephard L, Horne A . Diagnosis and management of ectopic pregnancy. J Fam Plann Reprod Health Care. 2011; 37(4):231-40. PMC: 3213855. DOI: 10.1136/jfprhc-2011-0073. View

17.

Li J, Jiang K, Zhao F . Fertility outcome analysis after surgical management of tubal ectopic pregnancy: a retrospective cohort study. BMJ Open. 2015; 5(9):e007339. PMC: 4563265. DOI: 10.1136/bmjopen-2014-007339. View

18.

Kostrzewa M, Zyla M, Litwinska E, Kolasa-Zwierzchowska D, Szpakowski A, Stachowiak G . [Salpingotomy vs salpingectomy--a comparison of women's fertility after surgical treatment of tubal ectopic pregnancy during a 24-month follow-up study]. Ginekol Pol. 2014; 84(12):1030-5. DOI: 10.17772/gp/1675. View

19.

Fernandez H, Lelaidier C, Baton C, Bourget P, Frydman R . Return of reproductive performance after expectant management and local treatment for ectopic pregnancy. Hum Reprod. 1991; 6(10):1474-7. DOI: 10.1093/oxfordjournals.humrep.a137292. View

20.

Nieuwkerk P, Hajenius P, van der Veen F, Ankum W, Wijker W, Bossuyt P . Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate. Fertil Steril. 1998; 70(3):518-22. DOI: 10.1016/s0015-0282(98)00213-1. View